Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

35.46
Delayed Data
As of Feb 17
 +0.02 / +0.06%
Today’s Change
30.89
Today|||52-Week Range
57.81
-1.12%
Year-to-Date

Today’s Trading

Previous close35.44
Today’s open35.22
Day’s range35.19 - 35.46
Volume1,742,723
Average volume (3 months)3,729,481
Market cap$69.5B
Dividend yield3.74%
Data as of 4:02pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.80%
Revenue growth (last year)+3.81%
P/E ratio2.4
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.40+1.39%
ABTAbbott Laboratories+0.49+1.11%
SHPGShire+2.38+1.33%
LLYEli Lilly and Co+0.35+0.44%
Data as of 4:03pm ET, 02/17/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$0.50
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts


Search for Jobs